Pro MedicusPMDIY 77 Altman Z-Score is 148.04 as of Jun. 28, 2026, which is 193% above its 10-year median of 50.60. GuruFocus rates PMDIY with a GF Score™ of 77/100 and a GF Value™ of $31.72 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 657 Healthcare Providers & Services companies, Pro Medicus ranks better than 99.54% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 148.89 is strong.
Pro Medicus has a Altman Z-Score of 148.04, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Pro Medicus's Altman Z-Score or its related term are showing as below:
PMDIY'
s Altman Z-Score Range Over the Past 10 Years
Min: 26.98 Med: 50.6 Max: 222.64
Current: 148.89
During the past 13 years, Pro Medicus's highest Altman Z-Score was 222.64. The lowest was 26.98. And the median was 50.60.
Pro Medicus (OTCPK:PMDIY) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Pro Medicus Altman Z-Score Related Terms
Pro Medicus Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Pro Medicus's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMDIY vs VEEV, BTSG, TEM: Altman Z-Score Comparison
For the Health Information Services subindustry, Pro Medicus's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro Medicus Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Pro Medicus's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Pro Medicus's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.6996
+
1.4
*
0.707
+
3.3
*
0.4822
+
0.6
*
239.9883
+
1.0
*
0.6286
=
148.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Pro Medicus (PMDIY) has a Altman Z-Score of 148.04 as of Jun. 28, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Pro Medicus and its competitors. This is 193% above median its historical median of 50.60. Over the past decade, Pro Medicus' Altman Z-Score has ranged from 26.98 to 222.64. According to the industry distribution chart, Pro Medicus ranks #3 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 0.5%.
Is Pro Medicus' Altman Z-Score too high?
Pro Medicus' current Altman Z-Score of 148.04 is 193% above median its 10-year median of 50.60. Over the past 10 years, this metric has ranged from a low of 26.98 to a high of 222.64. The Healthcare Providers & Services industry median Altman Z-Score is 2.38. Pro Medicus' value of 148.04 is 6120.2% above this industry median. Based on the distribution chart, Pro Medicus ranks #3 out of 657 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pro Medicus has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' Altman Z-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Pro Medicus ranks #3 out of 657 companies for Altman Z-Score. This places Pro Medicus in the top 1% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.38. Pro Medicus' value of 148.04 is 6120.2% above this benchmark. Historically, Pro Medicus' own Altman Z-Score has ranged from 26.98 to 222.64 over the past decade. While the company's 10-year median is 50.60 vs. the industry median of 2.38, Pro Medicus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.38, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro Medicus's current Altman Z-Score of 148.04 is 6120.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Pro Medicus and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro Medicus's current Altman Z-Score is 148.04, which is 193% above median its own 10-year median of 50.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (PMDIY) is currently considered Significantly Undervalued. The stock's GF Value™ is $31.72, compared to a current price of $24.45 — trading 22.9% below its estimated fair value. The current Altman Z-Score is 148.04, which is 193% above median its 10-year median of 50.60 and 6120.2% above the Healthcare Providers & Services industry median of 2.38. Pro Medicus' overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Pro Medicus (PMDIY), the current Altman Z-Score is 148.04 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro Medicus (PMDIY) Overvalued in 2026?
Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued.
The current stock price of $24.45 is trading 22.9% below its estimated GF Value™ of $31.72.
GuruFocus considers Pro Medicus to be Significantly Undervalued.
Key valuation signals for PMDIY:
Altman Z-Score: 148.04 (193% above median its 10-year median of 50.60)
GF Value™: $31.72 vs. price of $24.45 (22.9% below fair value)
Industry Position: 6120.2% above the Healthcare Providers & Services median (#3 of 657)
No single metric tells the full story. See the PMDIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
77GF Score
Get the complete analysis for PMDIY
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMDIY has been successfully added to your 
